News
Enter your email address to get Core One Labs News Alerts.
Company News
Leading Microbiologist, Dr. Robert E.W. Hancock Appointed As Executive Chairman of Core One Labs Inc.
January 07, 2021
Vancouver, British Columbia, Canada – January 7, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
Core One Labs Completes Acquisition of Vocan Biotechnologies Inc.
December 31, 2020
Vancouver, British Columbia, Canada – December 31, 2020 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.
December 24, 2020
Vancouver, British Columbia, Canada – December 24, 2020 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A14XHT) (the “Company”) is pleased to announce...
Read more
Company News
Core One Labs Announces Resumption of Trading
December 03, 2020
Vancouver, British Columbia, Canada – December 2, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) (the “Company”)...
Read more
Company News
Core One Labs Provides Update on Financial Statements and Management Cease Trade Order
November 01, 2020
Vancouver, British Columbia, Canada – July 15, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABD), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”). The Company wishes...
Read more
Company News
Core One Labs Signs Letter of Intent to Sell Certain Assets
October 30, 2020
Vancouver, British Columbia, Canada – October 30, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABD), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more